Clinical Trial Update: Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial update on a radiolabeled monoclonal antibody for detection and staging in lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Gilead Sciences | Conditions: Lymphoma | Phase 3 | Status: UNKNOWN